Biktarvy
State of the ART: HIV Management in 2025
Earlier initiation of ART and better medication options have resulted in a narrowing in the mortality gap between ...
JULY 3, 2025
Crushing/Dissolving HIV Medication Effective for Hospitalized Patients
Providing dissolved or crushed Biktarvy through an enteral tube can achieve viral suppression and may be a good ...
JUNE 27, 2025
CDC Updates Nonoccupational Post-Exposure Prophylaxis HIV Recommendations
The CDC has issued updated recommendations for antiretroviral post-exposure prophylaxis (PEP) for nonoccupational ...
MAY 27, 2025
Study Finds 1 INSTI Combo Fares Better With Weight Gain
How do you pick which drug to prescribe for your patients with HIV?
MARCH 25, 2025
Good Results With Biktarvy in HIV–HBV Coinfection
At CROI 2025, Dr. Anchalee Avihingsanon and her colleagues reported Week 48 outcomes from the open-label extension ...
MARCH 18, 2025
Biktarvy’s Benefits Extend in Older Adults With HIV
Five-year follow-up data from the triple combination HIV therapy showed high rates of disease suppression and ...
FEBRUARY 20, 2025
Biktarvy’s Benefits Extend in Older Adults With HIV
Five-year follow-up data from the triple combination HIV therapy bictegravir-emtricitabine-tenofavir alafenamide ...
NOVEMBER 25, 2024
Studies Explore Simplifying HIV Treatment Regimens
Simplifying treatment regimens for people living with HIV may improve patients’ adherence and quality of ...
JUNE 14, 2024
FDA Approves Biktarvy Label Update With Data for Use During Pregnancy
The FDA approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy for ...
APRIL 29, 2024
FDA Expands Indication of Biktarvy for Resistant HIV
The FDA expanded the indication for bictegravir-emtricitabine-tenofovir alafenamide (B/F/TAF; Biktarvy, Gilead) to ...
FEBRUARY 29, 2024
Biktarvy Effective in Those With Adherence Challenges
BIC/FTC/TAF was effective in suppressing HIV viral load, even among adults who had adherence challenges
NOVEMBER 29, 2023
Faster Viral Suppression With Biktarvy Among Patients With Advanced HIV
Biktarvy is associated with faster CD4 cell count recovery and favorable virologic outcomes compared with other ...
MAY 5, 2023
